Clin2
NCT07343193Possibly a fitRecruiting

Reducing antipsychotic medication: a case study

Psychotic Disorder

Part of Mental health clinical trials.

This study looks at safely reducing or stopping antipsychotic medication in adults with psychotic disorders who are stable and interested in trying. It aims to understand how to best support patients during this process.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years or older.
  • You have been diagnosed with a psychotic or related disorder.
  • You have been taking antipsychotic medication for a long time.
  • Your symptoms are currently stable.
  • You want to try reducing or stopping your antipsychotic medication between January 2021 and October 2025.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07152184Not yet recruiting· Phase 2
Comparing antipsychotic dose reduction versus staying on current treatment

This study compares whether slowly reducing antipsychotic medication is as effective as staying on the current dose for people with schizophrenia or related disorders. It uses a personalized approach to help you and your doctor decide which option may work best for you.

NCT06562608Recruiting· Phase 4
Reducing Anticholinergic Medications in Schizophrenia

This trial is testing whether it is safe to slowly reduce or stop anticholinergic medications (benztropine or trihexyphenidyl) in people with schizophrenia. It aims to see if stopping these drugs can help with thinking and memory without causing worsening movement problems.

Pittsburgh, Pennsylvania
NCT06796946Not yet recruiting· Early Phase 1
Supporting safe antidepressant reduction in primary care

This study looks at helping people safely reduce or stop their antidepressant medication with support from their primary care team. It aims to find the best ways to guide patients through this process.

Cadiz
NCT06961968Recruiting· Phase 3
Schizophrenia medication withdrawal study

This study tests whether patients with schizophrenia can safely stop or reduce their current medication without worsening symptoms. It is designed for people who need ongoing psychiatric care.

Rogers, Arkansas
NCT07393919Not yet recruiting· Phase 4
Stopping antidepressants for depression in remission

This trial compares different ways to safely stop taking an antidepressant when your depression is in remission. It aims to find the best strategy to avoid withdrawal symptoms and keep you well.

NCT07114094Recruiting
Developing a tool to safely reduce medications in older adults

This study aims to create and test a tool that helps doctors decide which medications might be safely stopped or reduced for patients aged 60 and older. If you're an older adult visiting a general medicine or family medicine clinic, you may be able to help shape this tool.

Bangalore, Karnataka

Hear when a new Psychotic Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.